|
|
||||||||
B on 1,25-dihydroxyvitamin
D3 and retinoid X receptor function
1 Division of Endocrinology and Metabolism, Department of Medicine, Emory University School of Medicine and Veterans Affairs Medical Center, Atlanta, Georgia, 30033; and 2 German Cancer Research Center, D-69120 Heidelberg, Germany
Responsiveness to 1,25-dihydroxyvitamin
D3 [1,25(OH)2D3] may be
diminished in osteoporosis and inflammatory arthritis. The inflammatory
cytokine tumor necrosis factor-
(TNF-
) is produced in excess in
these disorders and has been shown to decrease osteoblast transcriptional responsiveness to vitamin D and to inhibit the binding
of the vitamin D receptor (VDR) and its nuclear partner the retinoid X
receptor (RXR) to DNA. Previous studies have shown that a vitamin D
(VDRE) or retinoid X DNA response element (RXRE) is sufficient to
confer TNF-
inhibition of vitamin D or retinoid-stimulated transcription in the absence of known TNF-
-responsive DNA sequences. We tested the hypothesis that the TNF-
-stimulated transcription factor nuclear factor (NF)-
B could, in part, mediate TNF-
action by inhibiting the transcriptional potency of the VDR and RXR at their
cognate cis regulatory sites. Osteoblastic ROS 17/2.8 cells transfected with a dose of NF-
B comparable to that stimulated by
TNF-
decreased 1,25(OH)2D3-stimulated
transcription. This inhibitory effect of NF-
B was not observed on
basal transcription of a heterologous reporter in the absence of the
VDRE. The effects of NF-
B and TNF-
were comparable but not
additive. COS-7 cells were cotransfected with reporters under the
regulation of VDRE or RXRE along with vectors expressing VDR, RXR, and
NF-
B nuclear proteins. Reconstituted NF-
B and the NF-
B subunit
p65 alone, but not p50, dose dependently suppressed basal and
ligand-stimulated transcription. p65 overexpression completely
abrogated enhanced VDRE-mediated transcriptional activity in response
to 1,25(OH)2D3. Electrophoretic mobility shift
experiments did not reveal a direct effect of recombinant NF-
B or
its individual subunits on the binding of heterodimeric VDR-RXR to DNA.
These results suggest that TNF-
inhibition of hormone-stimulated
transcriptional activation may be mediated by activation of NF-
B. In
contrast, the inhibitory effect of TNF-
on binding of receptors to
DNA is unlikely to be mediated by NF-
B and is not necessary for
inhibition of transcription.
nuclear factor-
B; tumor necrosis factor-
; vitamin D receptor; vitamin D
This article has been cited by other articles:
![]() |
K. Silbermann, G. Schneider, and R. Grassmann Stimulation of interleukin-13 expression by human T-cell leukemia virus type 1 oncoprotein Tax via a dually active promoter element responsive to NF-{kappa}B and NFAT J. Gen. Virol., November 1, 2008; 89(11): 2788 - 2798. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Gilbert, X. He, P. Farmer, J. Rubin, H. Drissi, A. J. van Wijnen, J. B. Lian, G. S. Stein, and M. S. Nanes Expression of the Osteoblast Differentiation Factor RUNX2 (Cbfa1/AML3/Pebp2alpha A) Is Inhibited by Tumor Necrosis Factor-alpha J. Biol. Chem., January 18, 2002; 277(4): 2695 - 2701. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |